File Download
  Links for fulltext
     (May Require Subscription)

Conference Paper: Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion

TitleClinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion
Authors
KeywordsMedical sciences
Oncology
Issue Date2011
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
Citation
The 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 4414 How to Cite?
AbstractBACKGROUND: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified oncogene responsible for 1q21 amplicon. This study aims to investigate the role of CHD1L in predicting prognosis and chemotherapy response of HCC patients ...
DescriptionPoster Presentations - New Target Models and Tumor Classification: abstract no. 4414
This journal suppl. entitled: Proceedings: AACR 102nd Annual Meeting 2011
Persistent Identifierhttp://hdl.handle.net/10722/137868
ISSN
2015 Impact Factor: 8.556
2015 SCImago Journal Rankings: 5.372

 

DC FieldValueLanguage
dc.contributor.authorChen, Len_US
dc.contributor.authorChan, HMen_US
dc.contributor.authorGuan, XYen_US
dc.date.accessioned2011-08-26T14:35:43Z-
dc.date.available2011-08-26T14:35:43Z-
dc.date.issued2011en_US
dc.identifier.citationThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 4414en_US
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/137868-
dc.descriptionPoster Presentations - New Target Models and Tumor Classification: abstract no. 4414-
dc.descriptionThis journal suppl. entitled: Proceedings: AACR 102nd Annual Meeting 2011-
dc.description.abstractBACKGROUND: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified oncogene responsible for 1q21 amplicon. This study aims to investigate the role of CHD1L in predicting prognosis and chemotherapy response of HCC patients ...-
dc.languageengen_US
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/-
dc.relation.ispartofCancer Researchen_US
dc.subjectMedical sciences-
dc.subjectOncology-
dc.titleClinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletionen_US
dc.typeConference_Paperen_US
dc.identifier.emailChen, L: pollyllc@hku.hken_US
dc.identifier.emailChan, HM: chantim@hkucc.hku.hken_US
dc.identifier.emailGuan, XY: xyguan@hkucc.hku.hken_US
dc.identifier.authorityGuan, XY=rp00454en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1158/1538-7445.AM2011-4414-
dc.identifier.hkuros190900en_US
dc.identifier.volume71-
dc.identifier.issue8 suppl. 1-
dc.publisher.placeUnited States-
dc.description.otherThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 4414-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats